Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy (2023) Harbeck N, Kates R, Schinköthe T, Schumacher J, Wuerstlein R, Degenhardt T, Lüftner D, et al. Journal article, Review article Is tebentafusp superior to combined immune checkpoint blockade and other systemic treatments in metastatic uveal melanoma? A comparative efficacy analysis with population adjustment (2023) Petzold A, Steeb T, Wessely A, Koch E, Vera J, Berking C, Heppt M Journal article, Review article Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review. (2017) Heppt MV, Steeb T, Schlager JG, Rosumeck S, Dressler C, Ruzicka T, Nast A, Berking C Journal article, Review article Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions (2017) Hassel JC, Heinzerling L, Aberle J, Baehr O, Eigentler TK, Grimm MO, Gruenwald V, et al. Journal article Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future (2015) Datta NR, Ordonez SG, Gaipl U, Paulides MM, Crezee H, Gellermann J, Marder D, et al. Journal article